Verdad Advisers, LP Hca Healthcare, Inc. Transaction History

Verdad Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$272.08 - $333.53 $248,953 - $305,179	-915 Reduced 49.46%	935 $311,000
Q4 2023 Feb 09, 2024	SELL	$221.81 - $275.85 $299,443 - $372,397	-1,350 Reduced 42.19%	1,850 $500,000
Q3 2023 Nov 13, 2023	SELL	$245.98 - $298.35 $767,457 - $930,852	-3,120 Reduced 49.37%	3,200 $787,000
Q2 2023 Aug 09, 2023	SELL	$264.09 - $303.48 $390,853 - $449,150	-1,480 Reduced 18.97%	6,320 $1.92 Million
Q1 2023 May 12, 2023	BUY	$243.35 - $263.81 $1.9 Million - $2.06 Million	7,800 New	7,800 $2.06 Million
Q2 2022 Aug 15, 2022	SELL	$168.06 - $275.16 $2.35 Million - $3.85 Million	-14,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$228.85 - $267.17 $3.2 Million - $3.74 Million	14,000 New	14,000 $3.51 Million

1,322

151M

1.4M

1.81M

Ticker HCA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 287,024,992
Market Cap $93.5B
Description
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surger...

Get notified when there are updates to the investment portfolio of Verdad Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Verdad Advisers, LP with notifications on news.